Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,683,000
-12,000 (-0.71%)
At close: Jan 2, 2026
Samsung Biologics Employees
Samsung Biologics had 4,770 employees as of December 31, 2024. The number of employees increased by 1,884 or 65.28% compared to the previous year.
Employees
4,770
Change
1,884
Growth
65.28%
Revenue / Employee
1.15B KRW
Profits / Employee
334.57M KRW
Market Cap
78.46T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4,770 | 1,884 | 65.28% |
| Dec 31, 2020 | 2,886 | 1,135 | 64.82% |
| Dec 31, 2017 | 1,751 | 413 | 30.87% |
| Dec 31, 2016 | 1,338 | - | - |
Samsung Biologics News
- 11 days ago - Samsung Biologics Expands U.S. Presence with $280M Acquisition - GuruFocus
- 11 days ago - Samsung Biologics acquires Human Genome Sciences from GSK - Seeking Alpha
- 11 days ago - Samsung Biologics To Acquire GSK's Rockville Facility For US$280 Mln - Nasdaq
- 11 days ago - Samsung Biologics to Acquire Human Genome Sciences from GSK - GuruFocus
- 2 months ago - Samsung BioLogics Co Ltd (XKRX:207940) Q3 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
- 3 months ago - Korean Stock Market Declines Amid Trade Uncertainty; Samsung Biologics (SSNLF) Drops - GuruFocus
- 3 months ago - Asian drug market stocks slides: Trump’s 100% pharmaceutical tariffs shake market; broader impact on Japan likely minimal - The Times of India